We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis.
- Authors
Kehr, Sarah; Berg, Philipp; Müller, Susanne; Fiedler, Sarah A.; Meyer, Britta; Ruppert-Seipp, Gabriele; Witzenhausen, Cornelia; Wolf, Marc E.; Henkes, Hans H.; Oberle, Doris; Keller-Stanislawski, Brigitte; Funk, Markus B.
- Abstract
We present the long-term outcomes of 44 patients who developed cerebral venous sinus thrombosis after vaccination with the adenoviral vector ChAdOx1 nCoV-19 COVID-19 vaccine. Assessment of the Extended Glasgow Outcome Scale was performed within 3–6 months after the initial hospital admissions. Patient outcomes ranged from good recovery (13 patients, 29.6%) to moderate disability (11 patients, 25.0%) and severe disability or vegetative state (6 patients, 13.6%). Fatal outcomes were reported in 14 patients (31.8%).
- Subjects
SINUS thrombosis; CRANIAL sinuses; VENOUS thrombosis; IDIOPATHIC thrombocytopenic purpura; TREATMENT effectiveness; CEREBRAL veins; THROMBOPOIETIN receptors
- Publication
NPJ Vaccines, 2022, Vol 7, Issue 1, p1
- ISSN
2059-0105
- Publication type
Article
- DOI
10.1038/s41541-022-00491-z